MOLARMEDI PHARMACEUTICALS LIMITED

About GSTIN 37AASCM8483A1Z0

MOLARMEDI PHARMACEUTICALS LIMITED is a Public Limited Company registered under GST in Andhra Pradesh with GSTIN 37AASCM8483A1Z0. The GST registration was obtained on 30 April 2025. The current status of this GST registration is .

The PAN associated with this GSTIN is AASCM8483A. The registration type is Regular. The primary nature of business activities is Wholesale Business, Retail Business. This GST registration is linked to MOLARMEDI PHARMACEUTICALS LIMITED (CIN: U47721TN2025PLC176135).

GST Registration Details

GSTIN
37AASCM8483A1Z0
PAN Number
Legal Name
MOLARMEDI PHARMACEUTICALS LIMITED
Trade Name
Not Available
Status
GST Type
Regular
State / Jurisdiction
Andhra Pradesh (Code: 37)
Entity Type
Public Limited Company
Nature of Business
Wholesale Business, Retail Business
Registration Date
30 Apr 2025
Principal Place of Business
1-4-176/1, ground floor police colony road Vijayawada Andhra Pradesh

Linked Company Information

CIN
U47721TN2025PLC176135
Company Class
Public
Company Status
Active

Frequently Asked Questions

Is 37AASCM8483A1Z0 a valid GST number?

Yes, 37AASCM8483A1Z0 is a valid GSTIN registered under the Goods and Services Tax (GST) system in India. It belongs to MOLARMEDI PHARMACEUTICALS LIMITED in Andhra Pradesh. The current status of this registration is .

What is the legal name registered under 37AASCM8483A1Z0?

The legal name registered under GSTIN 37AASCM8483A1Z0 is MOLARMEDI PHARMACEUTICALS LIMITED.

What is the PAN linked to 37AASCM8483A1Z0?

The PAN (Permanent Account Number) linked to GSTIN 37AASCM8483A1Z0 is AASCM8483A. The first two digits of a GSTIN represent the state code (37 for Andhra Pradesh), followed by the 10-character PAN, an entity code, the letter 'Z', and a check digit.

Which company is 37AASCM8483A1Z0 linked to?

GSTIN 37AASCM8483A1Z0 is linked to MOLARMEDI PHARMACEUTICALS LIMITED (CIN: U47721TN2025PLC176135), a Public company registered in India.

Data last updated: 15 Feb 2026, 00:53 | Record updated: 15 Feb 2026